RxDoctor Payments Data

James Hsieh

Medical Oncology · Saint Louis, MONPI 1205854924

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,700 of the $10,110 with a category attached, or 86.1%. Every reported general payment came from a single manufacturer, Eisai Inc.. Reporting peaked in 2019 at $6,985 and has fallen 77.6% since, to $1,563 in 2021.

$10,110in general payments, 2019–2025

Across 12 payments — averaging $842.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$10K
$3,841,781in research payments, 2019–2025

Across 273 payments — averaging $14,072 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$2M
  • E.r. Squibb & Sons, L.L.C.$941K
  • Eisai Inc.$483K
  • Exelixis Inc.$437K
  • AstraZeneca$29K

What the payments were for

  • Consulting fees$8,70086%
  • Travel & lodging$1,28913%
  • Food & beverage$1211%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.12$10,110

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,110 in reported general payments places this provider in the 60th percentile of 144 medical oncology providers in Missouri.

See all medical oncology providers in Missouri

Other medical oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →